Anna Perdrix Rosell
Founder & Co-CEO , Sixfold Bioscience
Dr Anna Perdrix Rosell is the Founder & Co-CEO of Sixfold Bioscience, a biotechnology company focused on engineering delivery systems for gene therapeutics. Anna is passionate about developing novel technologies and bringing them from the lab into the clinic. With over eight years experience in oncology at King’s College London and the Francis Crick Institute, she leads Sixfold’s expanding preclinical program. Dr Perdrix Rosell is a current Royal Academy of Engineering SME Leader, is a member of the Advisory Board of the EPSRC funded Portabolomics consortium and has previously been recognised by the Forbes 30U30 in Science/Healthcare, Maserati’s Top 100 British Entrepreneurs and The Observer’s Rising stars in Science, amongst others.